• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

GATA3在早期膀胱尿路上皮癌局部复发中的作用。

Role of GATA3 in Early-Stage Urothelial Bladder Carcinoma Local Recurrence.

作者信息

Popov Hristo, Ghenev Peter, Stoyanov George S

机构信息

General and Clinical Pathology, Forensic Medicine and Deontology, Medical University of Varna, Varna, BGR.

Pathology, Complex Oncology Center, Shumen, BGR.

出版信息

Cureus. 2023 Sep 10;15(9):e44998. doi: 10.7759/cureus.44998. eCollection 2023 Sep.

DOI:10.7759/cureus.44998
PMID:37829946
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10565122/
Abstract

Background One of the most characteristic features of non-invasive urothelial carcinoma (UC) is its high recurrence rate. Guanine-adenine-thymine-adenine nucleotide sequence-binding protein 3 (GATA3), as a transcription factor, correlates with urothelial differentiation and has been reported with poor prognosis in high-grade UC and recurrence in breast malignancies. As such, we set out to study the specifics of GATA3 in non-invasive UC, emphasizing on prediction for recurrence. Methods The cohort comprised 163 patients, with a follow-up period of five years, including 109 pTa cases and 54 pT1 cases. Immunohistochemical expression of GATA3 was assessed using a histo score (H-score). Kaplan-Meier test was conducted for the time to recurrence, according to the level of expression of GATA3 and the indicators studied. Receiver operating characteristic (ROC) curve analysis was done to determine the role of accuracy and specificity of predictability of the indicators. Results Recurrence within the follow-up period was noted in 41.72% of cases. No recurrence relationship was established for age and gender. GATA3 expression showed a varying H-score. Using ROC curve analysis, a cut-off value of 155 divided UC expression levels into low and high, with a sensitivity of 72.7% and specificity of 78.7% (area under the curve=0.800, 95% confidence interval: 0.696-0.904, p<0.001), further showing an association between high levels of nuclear expression and risk of local recurrence (p<0.0001). Conclusion Herein we have described the sensitivity of high GATA3 expression in non-invasive UC of the urinary bladder and its relation to local recurrence, independent of gender, age, tumor differentiation, and stage.

摘要

背景 非侵袭性尿路上皮癌(UC)最典型的特征之一是其高复发率。鸟嘌呤 - 腺嘌呤 - 胸腺嘧啶 - 腺嘌呤核苷酸序列结合蛋白3(GATA3)作为一种转录因子,与尿路上皮分化相关,并且在高级别UC中预后不良以及在乳腺恶性肿瘤复发方面已有报道。因此,我们着手研究非侵袭性UC中GATA3的具体情况,重点在于预测复发。方法 该队列包括163例患者,随访期为五年,其中包括109例pTa病例和54例pT1病例。使用组织学评分(H评分)评估GATA3的免疫组化表达。根据GATA3的表达水平和所研究的指标,对复发时间进行Kaplan - Meier检验。进行受试者操作特征(ROC)曲线分析以确定指标预测的准确性和特异性的作用。结果 在41.72%的病例中观察到随访期内复发。年龄和性别与复发无相关性。GATA3表达显示出不同的H评分。使用ROC曲线分析,将截断值设为155可将UC表达水平分为低表达和高表达,敏感性为72.7%,特异性为78.7%(曲线下面积 = 0.800,95%置信区间:0.696 - 0.904,p < 0.001),进一步表明高水平核表达与局部复发风险之间存在关联(p < 0.0001)。结论 在此我们描述了膀胱非侵袭性UC中高GATA3表达的敏感性及其与局部复发的关系,这与性别、年龄、肿瘤分化和分期无关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b33a/10565122/f2e8ef4cb04a/cureus-0015-00000044998-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b33a/10565122/f0a2da7e9662/cureus-0015-00000044998-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b33a/10565122/6ceae55d3459/cureus-0015-00000044998-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b33a/10565122/f2e8ef4cb04a/cureus-0015-00000044998-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b33a/10565122/f0a2da7e9662/cureus-0015-00000044998-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b33a/10565122/6ceae55d3459/cureus-0015-00000044998-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b33a/10565122/f2e8ef4cb04a/cureus-0015-00000044998-i03.jpg

相似文献

1
Role of GATA3 in Early-Stage Urothelial Bladder Carcinoma Local Recurrence.GATA3在早期膀胱尿路上皮癌局部复发中的作用。
Cureus. 2023 Sep 10;15(9):e44998. doi: 10.7759/cureus.44998. eCollection 2023 Sep.
2
Reduced expression of GATA3 predicts progression in non-muscle invasive urothelial carcinoma of the urinary bladder.GATA3 表达降低预示着膀胱非肌肉浸润性尿路上皮癌的进展。
J Histotechnol. 2020 Mar;43(1):21-28. doi: 10.1080/01478885.2019.1667126. Epub 2019 Sep 24.
3
Expression of Gata Binding Protein 3 as a Prognostic Factor in Urogenital Lesions and Its Association With Morphology.Gata结合蛋白3在泌尿生殖系统病变中作为预后因素的表达及其与形态学的关系。
Cureus. 2023 Nov 29;15(11):e49635. doi: 10.7759/cureus.49635. eCollection 2023 Nov.
4
GATA3 immunohistochemical expression in invasive urothelial carcinoma.GATA3在浸润性尿路上皮癌中的免疫组化表达
Urol Oncol. 2016 Oct;34(10):432.e9-432.e13. doi: 10.1016/j.urolonc.2016.04.016. Epub 2016 May 27.
5
GATA3 immunohistochemistry in urothelial carcinoma of the upper urinary tract as a urothelial marker and a prognosticator.GATA3免疫组化在上尿路尿路上皮癌中作为尿路上皮标志物和预后指标的研究
Hum Pathol. 2017 Jun;64:83-90. doi: 10.1016/j.humpath.2017.04.003. Epub 2017 Apr 17.
6
GATA3 expression loss is linked to stage progression but is unrelated to prognosis in muscle-invasive urothelial carcinoma of the bladder.GATA3 表达缺失与分期进展相关,但与肌层浸润性膀胱癌的预后无关。
Hum Pathol. 2022 Dec;130:10-17. doi: 10.1016/j.humpath.2022.09.004. Epub 2022 Sep 21.
7
Diagnostic utility of GATA3 immunohistochemical expression in urothelial carcinoma.GATA3免疫组化表达在尿路上皮癌中的诊断效用
Indian J Pathol Microbiol. 2019 Apr-Jun;62(2):244-250. doi: 10.4103/IJPM.IJPM_228_18.
8
Diagnostic and Prognostic Roles of GATA3 Immunohistochemistry in Urothelial Carcinoma.GATA3 免疫组化在尿路上皮癌中的诊断和预后作用。
Medicina (Kaunas). 2023 Aug 11;59(8):1452. doi: 10.3390/medicina59081452.
9
Stratification of urothelial bladder carcinoma depending on immunohistochemical expression of GATA3 and CK5/6.根据 GATA3 和 CK5/6 的免疫组织化学表达对尿路上皮膀胱癌进行分层。
J Immunoassay Immunochem. 2021 Nov 2;42(6):662-678. doi: 10.1080/15321819.2021.1937212. Epub 2021 Jun 9.
10
Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung.GATA3 免疫组织化学在鉴别尿路上皮癌与前列腺腺癌,以及宫颈、肛门和肺的鳞状细胞癌中的应用。
Am J Surg Pathol. 2012 Oct;36(10):1472-6. doi: 10.1097/PAS.0b013e318260cde7.

引用本文的文献

1
Spindle Cell Renal Neoplasms: A Pathological Case Report on Primary Renal Leiomyosarcoma and Sarcomatoid Renal Cell Carcinoma.梭形细胞肾肿瘤:原发性肾平滑肌肉瘤和肉瘤样肾细胞癌的病理病例报告
Cureus. 2023 Oct 3;15(10):e46449. doi: 10.7759/cureus.46449. eCollection 2023 Oct.

本文引用的文献

1
Role of GATA3 in tumor diagnosis: A review.GATA3 在肿瘤诊断中的作用:综述。
Pathol Res Pract. 2021 Oct;226:153611. doi: 10.1016/j.prp.2021.153611. Epub 2021 Sep 13.
2
Reduced expression of GATA3 predicts progression in non-muscle invasive urothelial carcinoma of the urinary bladder.GATA3 表达降低预示着膀胱非肌肉浸润性尿路上皮癌的进展。
J Histotechnol. 2020 Mar;43(1):21-28. doi: 10.1080/01478885.2019.1667126. Epub 2019 Sep 24.
3
Diagnostic utility of GATA3 immunohistochemical expression in urothelial carcinoma.GATA3免疫组化表达在尿路上皮癌中的诊断效用
Indian J Pathol Microbiol. 2019 Apr-Jun;62(2):244-250. doi: 10.4103/IJPM.IJPM_228_18.
4
The use of intravesical BCG in urothelial carcinoma of the bladder.膀胱内卡介苗在膀胱尿路上皮癌中的应用。
Ecancermedicalscience. 2019 Feb 26;13:905. doi: 10.3332/ecancer.2019.905. eCollection 2019.
5
GATA3 as a master regulator and therapeutic target in ovarian high-grade serous carcinoma stem cells.GATA3作为卵巢高级别浆液性癌干细胞中的主要调节因子和治疗靶点。
Int J Cancer. 2018 Dec 15;143(12):3106-3119. doi: 10.1002/ijc.31750. Epub 2018 Oct 3.
6
GATA3 immunohistochemistry in urothelial carcinoma of the upper urinary tract as a urothelial marker and a prognosticator.GATA3免疫组化在上尿路尿路上皮癌中作为尿路上皮标志物和预后指标的研究
Hum Pathol. 2017 Jun;64:83-90. doi: 10.1016/j.humpath.2017.04.003. Epub 2017 Apr 17.
7
Bladder cancer.膀胱癌。
Nat Rev Dis Primers. 2017 Apr 13;3:17022. doi: 10.1038/nrdp.2017.22.
8
GATA3 immunohistochemical expression in invasive urothelial carcinoma.GATA3在浸润性尿路上皮癌中的免疫组化表达
Urol Oncol. 2016 Oct;34(10):432.e9-432.e13. doi: 10.1016/j.urolonc.2016.04.016. Epub 2016 May 27.
9
Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation?经尿道切除术后即刻单次灌注化疗与单纯经尿道切除治疗膀胱 pTa-pT1 期尿路上皮癌的随机对照试验的系统评价和个体患者数据分析:哪些患者从中获益?
Eur Urol. 2016 Feb;69(2):231-44. doi: 10.1016/j.eururo.2015.05.050. Epub 2015 Jun 16.
10
Epidemiology of bladder cancer.膀胱癌流行病学
Hematol Oncol Clin North Am. 2015 Apr;29(2):177-89, vii. doi: 10.1016/j.hoc.2014.10.001.